OPCH
Option Care Health, Inc.
Price Chart
Latest Quote
$21.30
-0.69 (-3.14%)
Current Price
| Previous Close | $21.99 |
| Open | $21.68 |
| Day High | $21.92 |
| Day Low | $21.19 |
| Volume | 1,499,939 |
Stock Information
| Shares Outstanding | 157.03M |
| Total Debt | $1.27B |
| Cash Equivalents | $181.85M |
| Revenue | $5.67B |
| Net Income | $206.19M |
| Sector | Healthcare |
| Industry | Medical Care Facilities |
| Market Cap | $3.34B |
| P/E Ratio | 16.64 |
| EPS (TTM) | $1.28 |
| Exchange | NMS |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $4.43B |
| Sales | $5.67B |
| Income | $206.19M |
| Book/sh | $8.61 |
| Cash/sh | $1.16 |
| Employees | 7K |
Financial Ratios
| Quick Ratio | 1.01 |
| Current Ratio | 1.64 |
| Debt/Eq | 94.01 |
| EPS Growth TTM | -3.00% |
Returns & Margins
| ROA | 6.19% |
| ROE | 15.26% |
| Gross Margin | 19.18% |
| Operating Margin | 5.37% |
| Profit Margin | 3.64% |
Ownership
| Insider Ownership | 1.20% |
| Institutional Ownership | 110.14% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | 10.39 |
| PEG | 1.23 |
| P/S | 0.59 |
| P/B | 2.48 |
Analyst Data
| Recommendation | buy |
| Target Price | $28.58 |
Technical Indicators
| SMA20 | $21.02 |
| SMA50 | $22.88 |
| SMA200 | $28.54 |
| RSI | 57.98 |
| ATR | 0.7157 |
| Shares Float | 145.90M |
| Short Float | 10.97% |
| Short Ratio | 2.49 |
| Volatility | 0.65 |
| Rel Volume | 0.58 |
Performance History
| Week | +2.60% |
| Month | -4.18% |
| Quarter | -24.36% |
| 6 Months | -35.40% |
| YTD | -33.93% |
| Year | -32.51% |
| 3 Years | -29.49% |
| 5 Years | +3.75% |
| 10 Years | +92.93% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-22 | $21.30 | 1,587,900 |
| 2026-06-18 | $21.99 | 3,558,000 |
| 2026-06-17 | $21.71 | 2,436,400 |
| 2026-06-16 | $21.62 | 1,949,900 |
| 2026-06-15 | $21.23 | 3,988,400 |
| 2026-06-12 | $20.76 | 3,055,100 |
| 2026-06-11 | $20.78 | 2,799,900 |
| 2026-06-10 | $21.38 | 4,669,400 |
| 2026-06-09 | $21.11 | 3,984,100 |
| 2026-06-08 | $20.08 | 3,053,600 |
| 2026-06-05 | $20.51 | 2,646,500 |
| 2026-06-04 | $20.07 | 2,510,700 |
| 2026-06-03 | $20.53 | 2,545,400 |
| 2026-06-02 | $20.54 | 1,616,300 |
| 2026-06-01 | $20.46 | 2,328,700 |
| 2026-05-29 | $20.87 | 2,359,400 |
| 2026-05-28 | $21.58 | 2,775,200 |
| 2026-05-27 | $21.64 | 2,386,400 |
| 2026-05-26 | $21.35 | 2,379,000 |
About Option Care Health, Inc.
Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides anti-infective therapy and services; home infusion services to treat heart failure; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders. It also offers treatments to manage the progression of neurological disorders, such as Duchenne muscular dystrophy, multiple sclerosis, Alzheimer's disease, and other neurological disorder; infusion therapies for bleeding disorders, such as hemophilia and von Willebrand diseases; therapies for women with high-risk pregnancies; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications, as well as nursing services. The company markets its services through patient referrals, including physicians, hospital discharge planners, hospital personnel, health maintenance organizations, and preferred provider organizations. The company is headquartered in Bannockburn, Illinois.
đ° Latest News
Is Option Care Health, Inc. (OPCH) A Good Stock To Buy Now?
Insider Monkey âĸ 2026-06-22T12:32:32Z
Should Goldmanâs Neutral Stance Amid Slower Growth Shift How OPCH Investors View Its Home-Infusion Moat?
Simply Wall St. âĸ 2026-06-13T20:09:33Z
Option Care Health (OPCH) Stock Trades Up, Here Is Why
StockStory âĸ 2026-06-09T20:46:14Z
Billionaire Stanley Druckenmillerâs Long-Term Healthcare Stock Pick: Option Care Health (OPCH)
Insider Monkey âĸ 2026-06-08T14:28:51Z
2 Reasons to Sell OPCH and 1 Stock to Buy Instead
StockStory âĸ 2026-06-01T18:24:51Z
How The Option Care Health (OPCH) Investment Story Is Evolving Without New Analyst Commentary
Simply Wall St. âĸ 2026-06-01T11:12:54Z
Q1 Earnings Outperformers: Option Care Health (NASDAQ:OPCH) And The Rest Of The Senior Health, Home Health & Hospice Stocks
StockStory âĸ 2026-05-28T11:42:27Z
3 Cash-Producing Stocks That Fall Short
StockStory âĸ 2026-05-26T10:59:49Z
BrightSpring Leans Into Home Care as IRA Pricing Resets Hit
Zacks âĸ 2026-05-25T17:25:00Z
BTSG Q1 2026 Beat Shows Drivers of Margin Expansion
Zacks âĸ 2026-05-25T16:19:00Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $4,558,472,000 | $3,982,620,000 | $3,318,102,000 | $3,072,948,000 |
| Cost Of Revenue | $4,561,624,000 | $3,985,209,000 | $3,321,101,000 | $3,077,817,000 |
| Total Revenue | $5,649,519,000 | $4,998,202,000 | $4,302,324,000 | $3,944,735,000 |
| Operating Revenue | $5,649,519,000 | $4,998,202,000 | $4,302,324,000 | $3,944,735,000 |
| Expenses | ||||
| Interest Expense | $54,558,000 | $49,029,000 | $51,248,000 | $53,806,000 |
| Total Expenses | $5,311,613,000 | $4,676,369,000 | $3,987,729,000 | $3,704,504,000 |
| Other Income Expense | $-448,000 | $10,795,000 | $95,395,000 | $19,343,000 |
| Other Non Operating Income Expenses | $-7,857,000 | $4,831,000 | $89,865,000 | $14,218,000 |
| Net Non Operating Interest Income Expense | $-54,558,000 | $-49,029,000 | $-51,248,000 | $-53,806,000 |
| Interest Expense Non Operating | $54,558,000 | $49,029,000 | $51,248,000 | $53,806,000 |
| Operating Expense | $749,989,000 | $691,160,000 | $666,628,000 | $626,687,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $207,585,000 | $211,823,000 | $267,090,000 | $150,556,000 |
| Net Interest Income | $-54,558,000 | $-49,029,000 | $-51,248,000 | $-53,806,000 |
| Normalized Income | $207,585,000 | $211,823,000 | $267,090,000 | $150,556,000 |
| Net Income From Continuing And Discontinued Operation | $207,585,000 | $211,823,000 | $267,090,000 | $150,556,000 |
| Total Operating Income As Reported | $337,906,000 | $321,833,000 | $314,595,000 | $240,231,000 |
| Net Income Common Stockholders | $207,585,000 | $211,823,000 | $267,090,000 | $150,556,000 |
| Net Income | $207,585,000 | $211,823,000 | $267,090,000 | $150,556,000 |
| Net Income Including Noncontrolling Interests | $207,585,000 | $211,823,000 | $267,090,000 | $150,556,000 |
| Net Income Continuous Operations | $207,585,000 | $211,823,000 | $267,090,000 | $150,556,000 |
| Pretax Income | $282,900,000 | $283,599,000 | $358,742,000 | $205,768,000 |
| Earnings From Equity Interest | $7,409,000 | $5,964,000 | $5,530,000 | $5,125,000 |
| Operating Income | $337,906,000 | $321,833,000 | $314,595,000 | $240,231,000 |
| Depreciation Amortization Depletion Income Statement | $67,538,000 | $60,909,000 | $59,201,000 | $60,565,000 |
| Depreciation And Amortization In Income Statement | $67,538,000 | $60,909,000 | $59,201,000 | $60,565,000 |
| Gross Profit | $1,087,895,000 | $1,012,993,000 | $981,223,000 | $866,918,000 |
| Per Share | ||||
| Diluted EPS | $1.27 | $1.23 | $1.48 | $0.83 |
| Basic EPS | $1.28 | $1.23 | $1.49 | $0.83 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $0 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $408,148,000 | $396,126,000 | $472,190,000 | $325,008,000 |
| Reconciled Depreciation | $70,690,000 | $63,498,000 | $62,200,000 | $65,434,000 |
| EBITDA (Bullshit earnings) | $408,148,000 | $396,126,000 | $472,190,000 | $325,008,000 |
| EBIT | $337,458,000 | $332,628,000 | $409,990,000 | $259,574,000 |
| Diluted Average Shares | $163,365,000 | $172,845,000 | $180,375,000 | $182,075,000 |
| Basic Average Shares | $162,099,000 | $171,567,000 | $178,973,000 | $181,105,000 |
| Diluted NI Availto Com Stockholders | $207,585,000 | $211,823,000 | $267,090,000 | $150,556,000 |
| Tax Provision | $75,315,000 | $71,776,000 | $91,652,000 | $55,212,000 |
| Selling General And Administration | $682,451,000 | $630,251,000 | $607,427,000 | $566,122,000 |
Fetched: 2026-06-20
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $-589,528,000 | $-437,018,000 | $-453,970,000 | $-511,436,000 |
| Total Assets | $3,455,769,000 | $3,421,743,000 | $3,217,035,000 | $3,112,936,000 |
| Total Non Current Assets | $2,190,801,000 | $2,099,116,000 | $2,122,780,000 | $2,118,597,000 |
| Other Non Current Assets | $44,394,000 | $43,965,000 | $42,349,000 | $40,313,000 |
| Goodwill And Other Intangible Assets | $1,915,921,000 | $1,841,256,000 | $1,875,642,000 | $1,897,539,000 |
| Other Intangible Assets | $309,178,000 | $301,010,000 | $335,396,000 | $364,115,000 |
| Current Assets | $1,264,968,000 | $1,322,627,000 | $1,094,255,000 | $994,339,000 |
| Other Current Assets | $87,629,000 | $112,198,000 | $98,744,000 | $98,330,000 |
| Inventory | $471,149,000 | $388,131,000 | $274,004,000 | $224,281,000 |
| Receivables | $473,566,000 | $409,733,000 | $377,658,000 | $377,542,000 |
| Accounts Receivable | $473,566,000 | $409,733,000 | $377,658,000 | $377,542,000 |
| Cash Cash Equivalents And Short Term Investments | $232,624,000 | $412,565,000 | $343,849,000 | $294,186,000 |
| Cash And Cash Equivalents | $232,624,000 | $412,565,000 | $343,849,000 | $294,186,000 |
| Non Current Deferred Assets | - | - | - | $0 |
| Non Current Deferred Taxes Assets | - | - | - | $0 |
| Prepaid Assets | - | - | - | - |
| Debt | ||||
| Net Debt | $928,208,000 | $698,588,000 | $718,801,000 | $770,018,000 |
| Total Debt | $1,273,347,000 | $1,217,973,000 | $1,166,412,000 | $1,155,025,000 |
| Long Term Debt And Capital Lease Obligation | $1,242,571,000 | $1,189,417,000 | $1,142,134,000 | $1,129,645,000 |
| Long Term Debt | $1,154,052,000 | $1,104,641,000 | $1,056,650,000 | $1,058,204,000 |
| Current Debt And Capital Lease Obligation | $30,776,000 | $28,556,000 | $24,278,000 | $25,380,000 |
| Current Debt | $6,780,000 | $6,512,000 | $6,000,000 | $6,000,000 |
| Other Current Borrowings | $6,780,000 | $6,512,000 | $6,000,000 | $6,000,000 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $2,129,376,000 | $2,017,505,000 | $1,795,363,000 | $1,726,833,000 |
| Total Non Current Liabilities Net Minority Interest | $1,300,028,000 | $1,237,359,000 | $1,177,054,000 | $1,161,482,000 |
| Other Non Current Liabilities | $1,438,000 | $366,000 | - | $9,683,000 |
| Non Current Deferred Liabilities | $56,019,000 | $47,576,000 | $34,920,000 | $22,154,000 |
| Non Current Deferred Taxes Liabilities | $56,019,000 | $47,576,000 | $34,920,000 | $22,154,000 |
| Current Liabilities | $829,348,000 | $780,146,000 | $618,309,000 | $565,351,000 |
| Payables And Accrued Expenses | $728,158,000 | $688,562,000 | $501,523,000 | $463,065,000 |
| Payables | $639,829,000 | $610,779,000 | $426,513,000 | $378,763,000 |
| Accounts Payable | $639,829,000 | $610,779,000 | $426,513,000 | $378,763,000 |
| Equity | ||||
| Common Stock Equity | $1,326,393,000 | $1,404,238,000 | $1,421,672,000 | $1,386,103,000 |
| Total Equity Gross Minority Interest | $1,326,393,000 | $1,404,238,000 | $1,421,672,000 | $1,386,103,000 |
| Stockholders Equity | $1,326,393,000 | $1,404,238,000 | $1,421,672,000 | $1,386,103,000 |
| Gains Losses Not Affecting Retained Earnings | $4,106,000 | $11,047,000 | $14,978,000 | $21,159,000 |
| Other Equity Adjustments | $4,106,000 | $11,047,000 | $14,978,000 | $21,159,000 |
| Retained Earnings | $876,921,000 | $669,336,000 | $457,513,000 | $190,423,000 |
| Other | ||||
| Treasury Shares Number | $27,664,622 | $17,585,613 | $8,330,022 | $383,722 |
| Ordinary Shares Number | $156,857,801 | $166,261,112 | $174,575,537 | $181,957,698 |
| Share Issued | $184,522,423 | $183,846,725 | $182,905,559 | $182,341,420 |
| Tangible Book Value | $-589,528,000 | $-437,018,000 | $-453,970,000 | $-511,436,000 |
| Invested Capital | $2,487,225,000 | $2,515,391,000 | $2,484,322,000 | $2,450,307,000 |
| Working Capital | $435,620,000 | $542,481,000 | $475,946,000 | $428,988,000 |
| Capital Lease Obligations | $112,515,000 | $106,820,000 | $103,762,000 | $90,821,000 |
| Total Capitalization | $2,480,445,000 | $2,508,879,000 | $2,478,322,000 | $2,444,307,000 |
| Treasury Stock | $818,201,000 | $507,598,000 | $255,107,000 | $2,403,000 |
| Additional Paid In Capital | $1,263,549,000 | $1,231,435,000 | $1,204,270,000 | $1,176,906,000 |
| Capital Stock | $18,000 | $18,000 | $18,000 | $18,000 |
| Common Stock | $18,000 | $18,000 | $18,000 | $18,000 |
| Preferred Stock | $0 | $0 | $0 | $0 |
| Long Term Capital Lease Obligation | $88,519,000 | $84,776,000 | $85,484,000 | $71,441,000 |
| Current Capital Lease Obligation | $23,996,000 | $22,044,000 | $18,278,000 | $19,380,000 |
| Pensionand Other Post Retirement Benefit Plans Current | $70,414,000 | $63,028,000 | $92,508,000 | $76,906,000 |
| Current Accrued Expenses | $88,329,000 | $77,783,000 | $75,010,000 | $84,302,000 |
| Goodwill | $1,606,743,000 | $1,540,246,000 | $1,540,246,000 | $1,533,424,000 |
| Net PPE | $230,486,000 | $213,895,000 | $204,789,000 | $180,745,000 |
| Accumulated Depreciation | $-129,814,000 | $-120,544,000 | $-123,871,000 | $-121,968,000 |
| Gross PPE | $360,300,000 | $334,439,000 | $328,660,000 | $302,713,000 |
| Leases | $126,651,000 | $116,675,000 | $99,725,000 | $99,085,000 |
| Construction In Progress | $19,207,000 | $22,990,000 | $33,668,000 | $29,411,000 |
| Other Properties | $127,747,000 | $124,187,000 | $121,102,000 | $107,366,000 |
| Machinery Furniture Equipment | $86,695,000 | $70,587,000 | $74,165,000 | $66,851,000 |
| Properties | $0 | $0 | $0 | $0 |
Fetched: 2026-06-20
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $217,140,000 | $287,786,000 | $329,429,000 | $232,189,000 |
| Operating Activities | ||||
| Operating Cash Flow | $258,447,000 | $323,392,000 | $371,295,000 | $267,547,000 |
| Cash Flow From Continuing Operating Activities | $258,447,000 | $323,392,000 | $371,295,000 | $267,547,000 |
| Operating Gains Losses | $-2,665,000 | $-5,587,000 | $-5,530,000 | $-14,528,000 |
| Investing Activities | ||||
| Capital Expenditure | $-41,307,000 | $-35,606,000 | $-41,866,000 | $-35,358,000 |
| Investing Cash Flow | $-161,083,000 | $-36,470,000 | $-56,506,000 | $-108,052,000 |
| Cash Flow From Continuing Investing Activities | $-161,083,000 | $-36,470,000 | $-56,506,000 | $-108,052,000 |
| Net Other Investing Changes | $-2,529,000 | $-864,000 | $-2,146,000 | $14,670,000 |
| Financing Activities | ||||
| Repurchase Of Capital Stock | $-309,951,000 | $-252,726,000 | $-250,261,000 | $0 |
| Financing Cash Flow | $-277,305,000 | $-218,206,000 | $-265,126,000 | $15,268,000 |
| Cash Flow From Continuing Financing Activities | $-277,305,000 | $-218,206,000 | $-265,126,000 | $15,268,000 |
| Net Other Financing Charges | $-1,037,000 | $3,327,000 | $-5,750,000 | - |
| Net Common Stock Issuance | $-309,951,000 | $-252,726,000 | $-250,261,000 | $0 |
| Dividend Received Cfo | $4,000,000 | $2,400,000 | $4,000,000 | $5,875,000 |
| Issuance Of Capital Stock | - | - | - | $0 |
| Common Stock Issuance | - | - | - | $0 |
| Other | ||||
| Repayment Of Debt | $-185,190,000 | $-6,384,000 | $-6,000,000 | $-6,000,000 |
| Issuance Of Debt | $229,472,000 | $49,959,000 | $0 | $0 |
| Interest Paid Supplemental Data | $64,658,000 | $71,553,000 | $69,804,000 | $50,372,000 |
| Income Tax Paid Supplemental Data | $67,287,000 | $64,522,000 | $75,241,000 | $13,438,000 |
| End Cash Position | $232,624,000 | $412,565,000 | $343,849,000 | $294,186,000 |
| Beginning Cash Position | $412,565,000 | $343,849,000 | $294,186,000 | $119,423,000 |
| Changes In Cash | $-179,941,000 | $68,716,000 | $49,663,000 | $174,763,000 |
| Proceeds From Stock Option Exercised | $-10,599,000 | $-12,382,000 | $-3,115,000 | $21,268,000 |
| Common Stock Payments | $-309,951,000 | $-252,726,000 | $-250,261,000 | $0 |
| Net Issuance Payments Of Debt | $44,282,000 | $43,575,000 | $-6,000,000 | $-6,000,000 |
| Net Long Term Debt Issuance | $44,282,000 | $43,575,000 | $-6,000,000 | $-6,000,000 |
| Long Term Debt Payments | $-185,190,000 | $-6,384,000 | $-6,000,000 | $-6,000,000 |
| Long Term Debt Issuance | $229,472,000 | $49,959,000 | $0 | $0 |
| Net Business Purchase And Sale | $-117,247,000 | $0 | $-12,494,000 | $-87,364,000 |
| Purchase Of Business | $-117,247,000 | $0 | $-12,494,000 | $-87,364,000 |
| Net PPE Purchase And Sale | $-41,307,000 | $-35,606,000 | $-41,866,000 | $-35,358,000 |
| Purchase Of PPE | $-41,307,000 | $-35,606,000 | $-41,866,000 | $-35,358,000 |
| Change In Working Capital | $-99,750,000 | $-20,246,000 | $-21,445,000 | $-29,777,000 |
| Change In Other Working Capital | $6,881,000 | $3,420,000 | $-8,372,000 | $-15,335,000 |
| Change In Other Current Liabilities | $-24,034,000 | $-21,911,000 | $-17,529,000 | $-21,395,000 |
| Change In Payables And Accrued Expense | $35,709,000 | $160,048,000 | $61,522,000 | $101,650,000 |
| Change In Accrued Expense | $16,186,000 | $-23,347,000 | $13,819,000 | $2,765,000 |
| Change In Payable | $19,523,000 | $183,395,000 | $47,703,000 | $98,885,000 |
| Change In Account Payable | $19,523,000 | $183,395,000 | $47,703,000 | $98,885,000 |
| Change In Prepaid Assets | $17,756,000 | $-15,601,000 | $-6,290,000 | $-16,798,000 |
| Change In Inventory | $-81,469,000 | $-114,127,000 | $-51,000,000 | $-41,010,000 |
| Change In Receivables | $-54,593,000 | $-32,075,000 | $224,000 | $-36,889,000 |
| Changes In Account Receivables | $-54,593,000 | $-32,075,000 | $224,000 | $-36,889,000 |
| Other Non Cash Items | $30,188,000 | $22,705,000 | $21,735,000 | $24,017,000 |
| Stock Based Compensation | $39,956,000 | $36,143,000 | $30,479,000 | $16,783,000 |
| Deferred Tax | $8,443,000 | $12,656,000 | $12,766,000 | $49,187,000 |
| Deferred Income Tax | $8,443,000 | $12,656,000 | $12,766,000 | $49,187,000 |
| Depreciation Amortization Depletion | $70,690,000 | $63,498,000 | $62,200,000 | $65,434,000 |
| Depreciation And Amortization | $70,690,000 | $63,498,000 | $62,200,000 | $65,434,000 |
| Earnings Losses From Equity Investments | $-7,409,000 | $-5,964,000 | $-5,530,000 | $-5,125,000 |
| Net Income From Continuing Operations | $207,585,000 | $211,823,000 | $267,090,000 | $150,556,000 |
Fetched: 2026-06-20